Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) HKSE

24.00

+0.24(+1.01%)

Updated at October 20 09:29AM

Currency In HKD

Valuation

Market Cap35.44B
Enterprise Value53.61B
P/E Ratio23.35
PEG Ratio1.99
Price/Sales Ratio1.89
Price/Book Ratio1.6
Enterprise/Revenue2.37
Enterprise/EBITDA18.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.13

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue41.07B
Revenue/Share15.2
Gross Profit19.7B
EBITDA8.6B
Net Income2.77B
Diluted EPS1.04

Balance Sheet

Total Cash15.64B
Total Cash/Share5.92
Total Debt32.21B
Total Debt/Equity0.68
Current Ratio0.95
Book Value Per Share22.85

Price History

52-Week Change65.69
52-Week High29
52-Week Low12.44
Moving Average 50 Days24.02
Moving Average 200 Days17.5

Statistics

Average Volume11.07M
Shares Outstanding3.34B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.32
Trailing Annual Dividend Yield1.11
Payout Ratio0.61
Last Split FactorN/A
Last Split DateN/A